key: cord-0781842-rooyzqau authors: Gomes Ribeiro, Heriks; Costa Silva Dantas-Komatsu, Raquel; Franco Pires Medeiros, Jeane; Clara da Cruz Carvalho, Maria; de Lima Soares, Victor; Zavarize Reis, Bruna; Ducati Luchessi, André; Nogueira Silbiger, Vivian title: Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection date: 2021-08-05 journal: Clin Chim Acta DOI: 10.1016/j.cca.2021.08.003 sha: 81ddcc16c23f73c63f1186ce81f202c99ad391c2 doc_id: 781842 cord_uid: rooyzqau BACKGROUND: The relationship of vitamin D status and other biochemical parameters with the risk of SARS-CoV-2 infection remains inconclusive, especially in regions with high solar incidence. Therefore, we aimed to associate the 25-hydroxyvitamin D (25(OH)D) concentrations and lipid profile prior to the SARS-CoV-2 tests in a population from a sunny region in Brazil (5° S, 35° W). METHODS: This retrospective cohort study enrolled 1634 patients tested for SARS-CoV-2 of a private medical laboratory with 25(OH)D concentration and lipid profile measured ≥7 days before the date of the first SARS-CoV-2 RT-PCR test and were categorized according to 25(OH)D sufficiency (≥ 30 ng/ml) or insufficiency (< 30 ng/ml). Multiple logistic regression analyses were performed to assess risk factors associated with positive tests for SARS-CoV-2. RESULTS: Average serum 25(OH)D was 33.6 ng/ml. The vitamin D deficiency (< 20 ng/ml) reached only 2.6% of the participants. Multivariate analysis demonstrated that patients > 49 y with insufficient 25(OH)D (< 30 ng/ml) presented increased odds to test positive for SARS-CoV-2 (OR: 2.02, 95%CI: 1.15 to 3.55, P = 0.015). The same is observed among those with total cholesterol > 190 mg/dl (OR: 1.90, 95%CI: 1.10 to 3.28, P = 0.020). CONCLUSIONS: Previous insufficient 25(OH)D (< 30 ng/ml) concentration and high total cholesterol were associated with SARS-CoV-2 infection among adults >48 y in the study population. Further studies should be conducted to confirm whether measurement of 25(OH)D and lipid profile could be useful to identify patients who are more susceptible to COVID-19. Vitamin D is an immunomodulatory hormone which performs metabolic functions related to adaptive and innate immunity with proven efficacy against various upper respiratory infections [1] [2] [3] . Its deficiency is gaining prominence in the current pandemic caused by the SARS-CoV-2 virus [4, 5] . Some studies have shown an association between insufficient vitamin D status and major symptom complications in COVID-19 due to impaired immune function [6] [7] [8] . An adequate serum concentration was associated with decreased 'cytokine storm', a severe manifestation of COVID-19 [9] which occurs through lysosomal enzyme expression and nitric oxide release, mitigating the hyperinflammatory response [10] . Vitamin D also influences the expression of toll-like receptors which recognize pathogenic proteins and articulate the immune response [11] . There are also discussions about the potential role of vitamin D in reducing the risk of infection and the development of COVID-19 [12, 13] . This antiviral function is related to mechanisms that block viral entry into cells, suppress viral replication and cell autophagy, and strengthen the body's immune defense against viral infection [14, 15] . Although vitamin D deficiency is commonly seen among patients with COVID-19 [16] [17] [18] , the predictor role of 25-hydroxyvitamin D (25(OH)D) status for disease risk remains inconclusive. Some retrospective studies observed that lower 25(OH)D concentrations were associated with a worse prognosis in COVID-19 hospitalized patients [19] [20] [21] . Furthermore, the threat of severe COVID-19 in patients with impaired metabolic health (such as dyslipidemia) is much higher than that of the general population [22, 23] , and whether metabolic health combined with prolonged vitamin D insufficiency predispose individuals to virus infection remains unknown. However, caution is needed when interpreting 25(OH)D values among hospitalized patients, since vitamin D concentrations may be subject to the effect of critical illness [24, 25] . Thus, research involving 25(OH)D analysis before being tested for SARS-CoV-2 infection is essential for this understanding [26, 27] . SARS-CoV-2 patients tested at the DNA Center Laboratory (Natal, Brazil) from April 1 st to December 31 st , 2020, with serum 25(OH)D and lipid profile performed from April 1 st to June 30 th , 2020, were recruited for a retrospective study. Natal is a city in northeastern Brazil located at 5 degrees south latitude, and has a high solar radiation intensity [28] . Patients who had their data available in the DNA Center Laboratory database (SoftLab © program -ND Engenharia e Software) were included in the analysis. This study was reviewed and approved by the Ethics Committee of the Federal University of Rio Grande do Norte, with a consent waiver for the use of non-identifiable data. No data to allow personal identification of the participants was made available. Retrospective data was collected from 25(OH)D, total cholesterol, high-density lipoprotein (HDL), non-HDL cholesterol (nHDL), and triglyceride serum concentration. Retrospective data were collected from 1634 patients tested for SARS-CoV-2. Data regarding 25(OH)D and lipid profile were obtained from the most recent collection before the SARS-CoV-2 test, regardless of positive or negative result. Patients who had serum analysis taken up to 7 days before the date of the first SARS-CoV-2 test were excluded from the study to avoid possible confounding due to potential early manifestations of infection. Patients who reported the use of any vitamin D supplement and those who had 25(OH)D ≥ 100 ng/ml (risk of vitamin D toxicity) [29] were also excluded. After the exclusions, data from 982 individuals were included in this study ( Figure 1 ). The SARS-CoV-2 infection diagnosis was determined by real-time reversetranscription-polymerase-chain-reaction assay (RT-PCR) with nasopharyngeal and oropharyngeal swab according to the protocol from the Centers for Disease Control and The non-high density lipoprotein cholesterol (non-HDL-C) concentrations were calculated by the formula: non-HDL-C = total cholesterol minus HDL-C [31] . Total cholesterol, HDL-C, non-HDL-C, LDL-C and triglycerides were categorized according to the V Brazilian Guideline for Dyslipidemias and Prevention of Atherosclerosis [32] . Statistical analysis was performed using SPSS ® 22.0 software program (and R version 3.6.1 using the ggplot2 package [33] . Normal distribution was evaluated using the Kolmogorov-Smirnov test. All variables are presented as the median and interquartile range (25% -75%) and were compared using Mann-Whitney tests. Categorical variables were compared by the chi-squared test. The evaluation of odds factors associated with SARS-CoV-2 test results was conducted using the multivariate model of logistic regression following the stepwise method to select the model variables. Odds Ratio (OR) were estimated with a 95% confidence interval (95% CI). A p < 0.05 was considered significant. A total of 982 patients (70.7% female, mean age 45 ± 16 years) were enrolled, and 258 (26.3%) tested positive for SARS-CoV-2 ( Table 1 ). The frequency of individuals with 25(OH)D < 20 ng/ml was 2.6% (26 patients). 25(OH)D status was associated with age and serum lipid profile, but not associated with the SARS-CoV-2 test (Table 1) Table 2 ). The same is observed among those with Total Cholesterol >190 mg/dL (OR: 1.90, 95%CI: 1.10-3.28, P = 0.020, Table 2 ). The cumulative odds for SARS-CoV-2 infection is 3.92 (Table 2) (Table S1 ). Our study was performed in a region with high solar radiation intensity and shows the Vitamin D might play a critical role in regulating the immunological response. Studies have found the modulating role of vitamin D in immune function through effects on dendritic and T cells [40] , which may promote viral clearance, reduce inflammatory responses, and decreased interleukin-6 concentrations, which are targets for controlling cytokine storm in COVID-19 [41, 42] . The serum threshold for vitamin D deficiency and sufficiency is still divergent in the literature, and an international consensus is lacking [43] . In our study, we used the serum threshold recommended by the European Society [29] and the Brazilian Society of Endocrinology and Metabolism [44] , but an optimal value for preventing infectious diseases has not been established. Our findings show a low prevalence of vitamin D deficiency (< 20 ng/ml) when compared to other studies [35, 36] , which is probably explained by the significant exposure to sunlight [45] since our study was carried out in a city 5 degrees south of the equator and with high solar radiation concentrations throughout the year [28] . Nevertheless, we observed a relationship between insufficient vitamin D and high total cholesterol with the incidence of SARS-CoV-2 infection in older people (> 49 y). Cholesterol is being recognized as a molecule involved in regulating the entry of the SARS-CoV-2 virus into the host cell. Cholesterol is necessary for forming lipid rafts, where a greater amount of angiotensinogen converting enzyme (ACE2) receptors are concentrated, which are the gateway to the virus. This in turn affects membrane permeability, signaling and transport [46] . An experimental study [47] This study has several limitations. First, the SARS-CoV-2 infection outcomes were only evaluated by viral RNA detection, and no other detection methods (viral antigen detection and serum antibody detection) nor clinical symptoms. Second, the RT-PCR is the gold standard to detect SARS-CoV-2 nucleic acids present in nasopharyngeal fluids; however, the false-negative rate for SARS-CoV-2 by RT-PCR testing is highly variable, as it is highest within the first 5 days after exposure (up to 67%), and lowest on day 8 after exposure (21%) [50] . Clinical data were not evaluated in our study, so it was not considered which day after exposure or symptoms the patient collected swabs for the SARS-CoV-2 test. Third, because the patients usually had several comorbidities and were subjected to a diverse medication regimen, the results could have been affected by the heterogeneity of the sample. Fourth, the relatively low sample size in this study may have inadequate power to exclude small but meaningful laboratory differences between the groups. Further prospective studies should be conducted to confirm the existence of a causal relationship between vitamin D, cholesterol, and SARS-CoV-2 infection. Moreover, large multicenter studies are necessary to determine whether 25(OH)D concentrations and lipid profile could be useful to identify patients who are more susceptible to COVID-19. Exploring links between vitamin D deficiency and COVID-19 Vitamin D modulation of innate immune responses to respiratory viral infections Modulation of the immune response to respiratory viruses by vitamin D Mechanisms in endocrinology: vitamin D and COVID-19 The association between vitamin D deficiency and community-acquired pneumonia: a meta-analysis of observational studies Vitamin D concentrations and COVID-19 infection UK Biobank The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients Vitamin D insufficiency is prevalent in severe COVID-19 COVID-19 cytokine storm: the interplay between inflammation and coagulation 25-dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Letter: Covid-19, and vitamin D The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37 Human antimicrobial peptides as therapeutics for viral infections Vitamin D status in hospitalized patients with SARS-CoV-2 infection Impact of vitamin d deficiency on COVID-19-A prospective analysis from the CovILD registry Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital Vitamin D deficiency is inversely associated with covid-19 incidence and disease severity in Chinese people Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study Sexspecific association between vitamin D deficiency and COVID-19 mortality in older patients Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis Obesity and impaired metabolic health in patients with COVID-19 Vitamin D Status and COVID-19 Clinical Outcomes in Hospitalized Patients Does serum 25-hydroxyvitamin D decrease during acutephase response? A systematic review Association of vitamin D status and other clinical characteristics with COVID-19 test results Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25 (OH)-vitamin D status: study of 1326 cases from the UK Biobank Natal UV radiation. Natal (RN/Brazil): Laboratory of tropical environmental variables, Ministry of Science Evaluation, treatment, and prevention of vitamin D 513 deficiency: An endocrine society clinical practice guideline Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol concentrations from the standard lipid profile Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges Update of the Brazilian Dyslipidemia and Atherosclerosis Prevention Directive Elegant Graphics for Data Analysis Vitamin d binding protein and 25-hydroxyvitamin d concentrations: emerging clinical applications SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D concentrations Association of Vitamin D Concentrations, Race/Ethnicity, and Clinical Characteristics With COVID-19 Test Results New insights on intercontinental origins of paternal lineages in Northeast Brazil MtDNA structure: The women who formed the Brazilian Northeast Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank Vitamin D and inflammatory diseases Correlation of vitamin D with inflammatory cytokines, atherosclerotic parameters, and lifestyle factors in the setting of heart failure: a 12-month follow-up study HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society Reference values of 25-hydroxyvitamin D revisited: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC) The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications The role of high cholesterol in agerelated COVID19 lethality Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection Low HDL and high triglycerides predict COVID-19 severity Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure Sex, female (% within stratum) , median (IQR), mg/dL 194 HDL cholesterol, median (IQR), mg/dL 51 mg/dL Abbreviations: nND, not determined; 25(OH)D, 25-hydroxyvitamin D; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2 Association of age tertiles with 25(OH)D and lipid profile in negative and positive SARS-CoV-2 test. A) Plasma concentrations of 25(OH)D (vertical axis), B) Plasma concentrations of total-cholesterol, C) Plasma concentrations of HDL cholesterol, D) Plasma concentrations of LDL cholesterol, E) Plasma concentrations of triglycerides, F) Plasma concentrations of HDL cholesterol, and 3 tertiles Abbreviations: 25(OH)D, 25-hydroxyvitamin D; nHDL cholesterol, non-HDL Cholesterol SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2 Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 and 25(OH)D increase the odds for a SARS-CoV-2 positive test OH)D <30 ng/mL showed higher Cholesterol and Triglyceride levels • There was no difference in the frequency of COVID-19 according to vitamin D status VNS and HGR designed and executed the study; HGR, RCSDK, JFPM, MCCC, and BZR wrote the paper;ADL performed statistical analysis of the data; VLS contributed to the execution of the study; VNS, ADL, and BZR revised the final draft of the manuscript.All authors read and approved the final manuscript.